HCL Healthcare opens Bengaluru office to deepen enterprise client engagement
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
By cutting pain crises & boosting haemoglobin
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
Subscribe To Our Newsletter & Stay Updated